Ralf Illing: Proud to Contribute My Patient Voice to OCEANIC-STROKE Research
Ralf Illing, Program and Solution Manager, Data and Systems Integration, STO at GE Healthcare, shared on LinkedIn about a recent article he contributed to, adding:
”Proud to share that I contributed as a patient author to a peer-reviewed publication in Future Neurology:
‘Plain language summary of publication of the OCEANIC-STROKE Phase 3 study design: evaluating asundexian for preventing secondary strokes’
Sharma, Illing et al. | Future Neurology, 21(1), 2026
OCEANIC-STROKE is a global Phase 3 clinical trial involving approximately 12,300 participants across 37 countries, investigating whether asundexian – an oral Factor XIa inhibitor – can reduce the risk of secondary stroke when added to standard antiplatelet therapy, with minimal impact on bleeding risk.
As a stroke survivor myself, I was invited to co-author this plain language summary – a format designed to make complex clinical research accessible to patients, caregivers, and non-specialist healthcare providers.
Why does this matter?
Clinical trials generate critical evidence. But that evidence only creates real-world impact when patients and their families can actually understand it.
Plain language summaries bridge that gap – and patient authors help ensure the language truly reflects lived experience.
I believe that meaningful patient involvement in research – not just as participants, but as contributors and communicators – is essential for advancing patient-centered medicine.
The full results of OCEANIC-STROKE are yet to be published.
I look forward to seeing what they mean for the stroke community.”
Title: Plain language summary of publication of the OCEANIC-STROKE Phase 3 study design: evaluating asundexian for preventing secondary strokes
Authors: Mukul Sharma, Ralf Illing, Pablo Colorado, Jennifer Gilbride, Lars Keller, Eva Muehlhofer, Ashkan Shoamanesh
Read the Full Article on Future Neurology
Stay updated on all scientific advances with Hemostasis Today.
-
May 11, 2026, 16:52Luke McLaughlin: Raising Awareness on Haemophilia Issues at ENIL Lead On
-
May 11, 2026, 16:49Jeff Sternlicht: Normal LDL Does Not Always Mean Low Risk
-
May 11, 2026, 16:42Archil Jaliashvili: From Managing Blood to Managing Oxygen Metabolism
-
May 11, 2026, 16:42Heghine Khachatryan: Celebrating One Hundred Years of von Willebrand Disease with EHC
-
May 11, 2026, 16:34Jane Hankins: Excited to Have Been a Part of the Faculty of ASH CRTI LA
-
May 11, 2026, 16:28Conan McIlwrath at the Rare Bleeding Disorders Conference Representing The Haemophilia Society as Chair
-
May 11, 2026, 16:24Anna A. Avagyan: Presenting Armenia’s Experience at SIOP Europe 2026
-
May 11, 2026, 16:18Mohamed Elkhider: Raising Awareness on Aortic Dissection
-
May 11, 2026, 16:11David McIntosh: A Pensioner’s Reflections on Blood Donation